TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 160 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $944,000 | +0.4% | 8,160 | -14.3% | 0.04% | +6.1% |
| Q1 2018 | $940,000 | -15.2% | 9,519 | -10.0% | 0.03% | -15.4% |
| Q4 2017 | $1,108,000 | -9.9% | 10,579 | -3.1% | 0.04% | -11.4% |
| Q3 2017 | $1,230,000 | -47.1% | 10,918 | -47.3% | 0.04% | -48.2% |
| Q2 2017 | $2,323,000 | -3.6% | 20,733 | +0.4% | 0.08% | +1.2% |
| Q1 2017 | $2,409,000 | +42.5% | 20,656 | +28.6% | 0.08% | +31.2% |
| Q4 2016 | $1,691,000 | -1.7% | 16,060 | +3.2% | 0.06% | +10.3% |
| Q3 2016 | $1,720,000 | +8.5% | 15,561 | +42.9% | 0.06% | +45.0% |
| Q2 2016 | $1,585,000 | -0.8% | 10,887 | -2.3% | 0.04% | +5.3% |
| Q1 2016 | $1,597,000 | – | 11,147 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
| Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
| Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
| Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
| FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
| MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
| Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
| ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |